This article reviews the scope, key principles, methodological expectations, and regulatory implications of ICH E20, and ...

In this Q&A, Mark Freitas, managing director and life sciences practice lead at Alvarez & Marsal, discusses how clinical ...

India’s strategy of multialignment, rooted in self-interest rather than ideology, produces both synergy and friction with the ...

Fell 14%, with the reduction in corporate expenses as a primary driver. Adjusted EBITDA -- Increased by $3.1 million; ...

Justin Crane explains why the Somerville, MA, Fire Department's Assembly Fire Station exemplifies how firefighter health and ...

For decades, the primes have been the backbone of the defense industrial base, leading the development and delivery of ...

When this is done well, biomarkers accelerate decision-making, reduce uncertainty, and ultimately bring improved therapies to patients faster. When this is done poorly, however, biomarkers can add ...

Peptide therapeutics require tailored ADME strategies to address stability, supporting more effective and reliable drug ...

Discover what structural change is and explore its causes, from technological innovation to geopolitical conflict, along with ...

In the latest episode of IPWatchdog Unleashed, I spoke with Brent Bellows about the policy and business realities of ...

The 5th Circuit’s ruling on mifepristone “is bad for health care access, and it’s also bad for innovation,” writes Grace E.